US charges Cassava Sciences, two former executives for misleading claims about Alzheimer's clinical trial-February 2024-www.financetom.com

US charges Cassava Sciences, two former executives for misleading claims about Alzheimer's clinical trial

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US charges Cassava Sciences, two former executives for misleading claims about Alzheimer's clinical trial

Sep 30, 2024 2:45 AM

WASHINGTON, Sept 26 (Reuters) - The U.S. Securities and

Exchange Commission said on Thursday that it charged Cassava

Sciences ( SAVA ) and two of the company's former executives for

misleading claims about the results of Alzheimer's clinical

trials.

The SEC said the company's founder and former CEO, Remi

Barbier, and its former senior vice president of neuroscience,

Dr. Lindsay Burns, will pay more than $40 million to settle

charges.

Previous page： Registrar Corp Acquires CMC Medical Devices to Make Global Compliance Quick and Easy Next page： Cinemark Q3 Earnings, Revenue Fall; Shares Up Pre-Bell

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Registrar Corp Acquires CMC Medical Devices to Make Global Compliance Quick and Easy

Nov 5, 2025

Expands Registrar Corp’s reach to support over 75% of the global medical device market. MALAGA, Spain & HAMPTON, Va.--(BUSINESS WIRE)-- Registrar Corp, a global leader in regulatory compliance and technology solutions and a Paine Schwartz Partners portfolio company, today announced the acquisition of CMC Medical Devices (CMC), a Spain-based provider of medical device regulatory, clinical, and compliance consulting services....

Cinemark Q3 Earnings, Revenue Fall; Shares Up Pre-Bell

Nov 5, 2025

06:57 AM EST, 11/05/2025 (MT Newswires) -- Cinemark (CNK) reported Q3 earnings Wednesday of $0.40 per diluted share, down from $1.19 a year earlier. Analysts polled by FactSet expected $0.48. Revenue for the quarter ended Sept. 30 was $857.5 million, compared with $921.8 million a year earlier. Analysts surveyed by FactSet expected $841.4 million. The company's shares were up 6%...

ODP Q3 revenue falls more than expected on decline in Office Depot division

Nov 5, 2025

Overview * ODP Q3 revenue falls 9% yr/yr, missing analyst expectations * Adjusted operating income beats estimates, despite revenue decline Outlook * ODP will not provide forward-looking guidance due to pending merger with Atlas Holdings * ODP expects merger with Atlas Holdings to close by end of 2025 Result Drivers * RETAIL STORE CLOSURES - Sales decline in Office Depot...

Stella-Jones Completes Acquisition of Brooks Manufacturing Co.

Nov 5, 2025

MONTREAL, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Stella-Jones Inc. ( STLJF ) (“Stella-Jones” or the “Company”) today announced that it has completed the previously announced acquisition of the assets of Brooks Manufacturing Co. (“Brooks”). The purchase price amounted to approximately US$140 million, subject to working capital adjustments. Brooks manufactures treated wood distribution crossarms and transmission framing components from their facility...